Franziska Michor
Insider
First SEC filing: June 22, 2026 · Latest: June 22, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 17, 2026 | RXRX | A | 88,424 | · | · | 215,477 Direct | +69.60% | Acquired | (price as of 2026-10-02) |
| June 18, 2025 | RXRX | A | 22,016 | · | · | 127,053 Direct | +20.96% | Acquired | (price as of 2026-10-02) |
| June 18, 2025 | RXRX | A | 44,031 | · | · | 44,031 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 20, 2024 | RXRX | A | 30,618 | · | · | 30,618 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 20, 2024 | RXRX | A | 15,335 | · | · | 45,953 Direct | +50.08% | Acquired | (price as of 2026-10-02) |
| Nov. 20, 2024 | RXRX | A | 17,694 | · | · | 63,647 Direct | +38.50% | Acquired | (price as of 2026-10-02) |
| Nov. 20, 2024 | RXRX | A | 41,390 | · | · | 105,037 Direct | +65.03% | Acquired | (price as of 2026-10-02) |
| Nov. 20, 2024 | RXRX | A | 30,670 | · | · | 30,670 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 20, 2024 | RXRX | A | 15,286 | · | · | 15,286 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 20, 2024 | RXRX | A | 17,694 | · | · | 17,694 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 20, 2024 | RXRX | A | 82,781 | · | · | 82,781 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2025 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $5.11 | June 18, 2035 | 44,031 | Acquired |
| Nov. 20, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $6.59 | May 2, 2033 | 30,670 | Acquired |
| Nov. 20, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $7.34 | May 16, 2033 | 15,286 | Acquired |
| Nov. 20, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $6.64 | May 14, 2034 | 17,694 | Acquired |
| Nov. 20, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $6.04 | Nov. 21, 2034 | 82,781 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).